|
⚲
|
| Keyboard |
| Morrow George J
✚
|
|
|---|---|
| CIK # | 0001068754 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001068754] | |
| 4 | [0001068754] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Morrow George J | |
| Neurocrine Biosciences Inc | |
| Align Technology Inc | |
| Vical Inc | |
| Otonomy Inc | |
| Safeway Inc | |
| Human Genome Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-25 | Sell | 15,000 | $143.37 | 2,150,550 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-11-25 | Option exercise | 15,000 | $47.89 | 718,350 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-11-25 | Option exercise | 15,000 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Align Technology Inc ALGN
Restricted Stock Units · derivative
|
2025-05-21 | Grant | 1,745 | $0.00 | |
|
Align Technology Inc ALGN
Common Stock
|
2025-05-21 | Option exercise | 1,148 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-21 | Grant | 3,318 | $0.00 | |
|
Align Technology Inc ALGN
Restricted Stock Units · derivative
|
2025-05-21 | Option exercise | 1,148 | $0.00 | |
|
Align Technology Inc ALGN
Restricted Stock Units · derivative
|
2024-05-22 | Grant | 1,148 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-22 | Grant | 2,869 | $0.00 | |
|
Align Technology Inc ALGN
Common Stock
|
2024-05-17 | Option exercise | 1,029 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-05-17 | Option exercise | 4,199 | $0.00 | |
|
Align Technology Inc ALGN
Restricted Stock Units · derivative
|
2024-05-17 | Option exercise | 1,029 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-17 | Option exercise | 4,199 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-14 | Option exercise | 20,000 | $39.79 | 795,800 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-14 | Sell | 20,000 | $139.41 | 2,788,200 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-14 | Option exercise | 20,000 | $39.79 | 795,800 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-14 | Sell | 20,000 | $139.42 | 2,788,400 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-03-14 | Option exercise | 20,000 | $39.79 | 795,800 |
| showing 20 of 134 most recent transactions | |||||